Non-canonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2022

Non-canonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias

Résumé

Cancer cell heterogeneity is a major driver of therapy resistance. To characterize resistant cells and their vulnerabilities, we studied the PLZF-RARA variant of acute promyelocytic leukemia (APL), resistant to retinoic acid (RA), using single-cell multi-omics. We uncovered transcriptional and chromatin heterogeneity in leukemia cells. We identified a subset of cells resistant to RA with proliferation, DNA replication and repair signatures, that depend on a fine-tuned E2F transcriptional network targeting the epigenetic regulator Enhancer of Zeste Homolog 2 (EZH2). Epigenomic and functional analyses validated the driver role of EZH2 in RA resistance. Targeting pan-EZH2 activities (canonical/non-canonical) was necessary to eliminate leukemia relapse initiating cells, which underlies a dependency of resistant cells on an EZH2 non-canonical activity and the necessity to degrade EZH2 to overcome resistance. Our study provides critical insights into the mechanisms of RA resistance that allow us to eliminate treatment-resistant leukemia cells by targeting EZH2, thus highlighting a potential targeted therapy approach. Beyond RA resistance and APL context, our study also demonstrates the power of single-cell multi-omics to identify, characterize and clear therapy-resistant cells.
Fichier principal
Vignette du fichier
1-s2.0-S0006497122010758-main.pdf (3.32 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : Copyright (Tous droits réservés)

Dates et versions

hal-03821719 , version 1 (09-11-2023)

Identifiants

Citer

Mathilde Poplineau, Nadine Platet, Adrien Mazuel, Léonard Hérault, Lia N’guyen, et al.. Non-canonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias. Blood, 2022, 140 (22), pp.2358-2370. ⟨10.1182/blood.2022015668⟩. ⟨hal-03821719⟩
56 Consultations
14 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More